The increasing R&D focus in dermatology and the need for well-executed global clinical trials has brought the two companies together to combine scientific and regulatory experience, relations with dermatology sites and global reach. TFS and SCIderm will jointly offer global and therapeutically aligned development services for life science companies with R&D in dermatology.
The partnership will target those dermatology companies in need of high level scientific and regulatory advice, access to dermatology investigators and managing the logistics and nuances associated with the conduct of larger multinational dermatology trials across Europe and North America.
TFS and SCIderm have been collaborating since 2011 in a variety of dermatological clinical trials and have established a proven working process, operational harmonization and a senior executive governance structure. The strategic partnership provides a reach of 200 investigational sites and access to more than 180,000 dermatological patients in Europe and North America.